Dianthus Therapeutics (DNTH) Receivables (2022 - 2025)
Dianthus Therapeutics (DNTH) recorded quarterly Receivables of $102000.0 in Q4 2025, down 98.0% quarter-over-quarter from $5.1 million in Q3 2025, and down 49.0% on a YoY basis from $200000.0 in Q4 2024.
Dianthus Therapeutics (DNTH) Receivables (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Receivables history runs 4 years deep, the most recent figure standing at $102000.0 for Q4 2025.
- In Q4 2025, Receivables fell 49.0% year-over-year to $102000.0; the TTM figure through Dec 2025 stood at $102000.0 (down 49.0% YoY), while the FY2025 annual figure was $102000.0, down 49.0% from the prior year.
- Receivables was $102000.0 for Q4 2025 at Dianthus Therapeutics, down from $5.1 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $5.6 million in Q4 2022 to a low of $39000.0 in Q2 2025.
- Historically, Receivables has averaged $1.7 million across 4 years, with a median of $800000.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Receivables jumped 259.52% in 2024, then tumbled 97.56% in 2025.
- A 4-year view of Receivables shows it stood at $5.6 million in 2022, then tumbled by 91.18% to $494000.0 in 2023, then tumbled by 59.51% to $200000.0 in 2024, then sank by 49.0% to $102000.0 in 2025.
- The last three Receivables figures came in at $102000.0 (Q4 2025), $5.1 million (Q3 2025), and $39000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | 102,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 800,000.00 |
| Dec 31, 2023 | 494,000.00 |
| Sep 30, 2023 | 751,000.00 |
| Dec 31, 2022 | 5.60 Mn |